Zolpidem in insomnia : a review. , EUROPEAN PSYCHIATRY, vol. 12, Suppl., 1997, pages 41S-48S, réf. 1p., ISSN 0924-9338, FRA
STOLLER (M.K.), BOYER (P.) / introd., LECRUBIER (Y.) / introd.
Insomnia affects about one-third of the population, and is associated with increased morbidity and mortality, reduced production and higher rates of accidents.
This suggests that insomnia may burden society with significant cost.
However, a precise economic analysis of insomnia is a challenge.
Insomnia is part of a very complex interplay of physical and psychological illness, functioning both as a cause and as a consequence.
In this paper, some of the methodological issues related to an economic analysis of insomnia are discussed.
Data is presented using an economic analysis as an organizer, thus illustrating what conclusions can be drawn, and where further research is needed.
Mots-clés BDSP : Facteur risque, Accident, Productivité, Morbidité, Mortalité, Economie santé, Homme, Trouble sommeil
Mots-clés Pascal : Aspect économique, Analyse coût, Insomnie, Facteur risque, Accident, Article synthèse, Productivité, Rendement professionnel, Morbidité, Mortalité, Economie santé, Homme, Trouble sommeil
Mots-clés Pascal anglais : Economic aspect, Cost analysis, Insomnia, Risk factor, Accident, Review, Productivity, Professional performance, Morbidity, Mortality, Health economy, Human, Sleep disorder
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0167308
Code Inist : 002B18C14. Création : 21/05/1997.